精品国产一区二区桃色

Member News

Academy elects new members

ASBMB Today Staff
June 7, 2021

The National Academy of Sciences has announced the election of 120 members — 59 of whom are women, the most elected in a single year — and 30 international members in recognition of their achievements in original research. Nine of those elected are members of the 精品国产一区二区桃色.

Pictured, from left, are Ta Yuan Chang, Michael L. Dustin, Vadim N. Gladyshev, Maureen R. Hanson and Joseph Heitman.
Pictured, from left, are Rachel Klevit, Geeta J. Narlikar, Margaret A. Phillips and Wilfred A. van der Donk.

is a professor in the department of biochemistry and cell biology at the Geisel School of Medicine, Dartmouth College. The Chang lab studies cholesterol homeostasis in the central nervous system and in systemic tissues, with a focus on investigating the biochemistry and physiological roles of the cholesterol storage enzyme acyl-coenzyme A: cholesterol acyltransferase 1, a membrane protein in the endoplasmic reticulum, in health and diseases. 

is a professor of molecular immunology and director of research at the Kennedy Institute of Rheumatology, University of Oxford. Dustin’s lab studies the immunological synapse and recently observed that the small vesicles enriched in T cell receptor, synaptic ectosomes, are directly budded into the immunological synapse, handing off T cell receptor and other cargo to the antigen-presenting cell.

is a professor of medicine at Harvard Medical School and director of redox medicine at Brigham and Women's Hospital. Gladyshev’s lab studies the molecular basis for natural changes in longevity and recently sequenced the genomes of the naked mole rat, the Brandt’s bat and other mammals, uncovering adaptations that contribute to their exceptional life spans.

is a professor in the department of molecular biology and genetics in the College of Agriculture and Life Sciences at Cornell University. The Hanson lab studies molecular and cell biology of plant organelles, photosynthesis and the pathophysiology and molecular biology of myalgic encephalomyelitis, also known as chronic fatigue syndrome.

is a professor and chair of the department of molecular genetics and microbiology at the Duke University School of Medicine. The Heitman lab discovered TOR and FKBP12 as targets of the immunosuppressive natural product rapamycin and defined nutrient sensing pathways in the model yeast Saccharomyces cerevisiae.  They study unisexual reproduction and mechanisms of pathogenesis and drug action and resistance with the pathogenic fungus Cryptococcus neoformans and other human fungal pathogens.

is a professor of chemistry and biochemistry in the department of biochemistry, University of Washington. The Klevit lab studies protein–protein interactions involved in quality control and repair, which play important roles in human disease, including projects in BRCA1, the breast cancer susceptibility protein; protein ubiquitination in general; and human small heat shock proteins alpha-B crystallin and HSP27.

is a professor in the department of biochemistry and biophysics at the University of California, San Francisco. Narlikar’s lab studies how the folding and compartmentalization of our genome is regulated to generate the many cell types that make up our body. Her laboratory has pioneered the application of sophisticated biophysical approaches to study the mechanisms of macromolecules that regulate genome organization.

is the chair of biochemistry and a professor in the departments of biochemistry and pharmacology at the University of Texas Southwestern Medical Center.  Phillips’ lab studies polyamine and nucleotide metabolism in African trypanosomes and is developing inhibitors of pyrimidine biosynthesis and polyamine biosynthesis to treat malaria and African sleeping sickness.

is a Howard Hughes Medical Institute investigator and chair of the department of chemistry, University of Illinois, Urbana–Champaign. The van der Donk lab focuses on the discovery, mode of action, and mechanism of biosynthesis of two classes of antibiotics: ribosomally synthesized and post-translationally modified peptides and phosphonate antibiotics.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Ralph G. Yount
In Memoriam

In memoriam: Ralph G. Yount

July 28, 2025

He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women鈥檚 health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.